Randomized Controlled Trial of Cetuximab Plus Chemotherapy for Patients With KRAS Wild-Type Unresectable Colorectal Liver-Limited Metastases | |
Ye, Le-Chi; Liu, Tian-Shu; Ren, Li; Wei, Ye; Zhu, De-Xiang; Zai, Sheng-Yong; Ye, Qing-Hai; Yu, Yiyi; Xu, Bo; Qin, Xin-Yu | |
刊名 | JOURNAL OF CLINICAL ONCOLOGY |
2013 | |
卷号 | 31期号:16 |
ISSN号 | 0732-183X |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4897206 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Ye, Le-Chi,Liu, Tian-Shu,Ren, Li,et al. Randomized Controlled Trial of Cetuximab Plus Chemotherapy for Patients With KRAS Wild-Type Unresectable Colorectal Liver-Limited Metastases[J]. JOURNAL OF CLINICAL ONCOLOGY,2013,31(16). |
APA | Ye, Le-Chi.,Liu, Tian-Shu.,Ren, Li.,Wei, Ye.,Zhu, De-Xiang.,...&Xu, Jianmin.(2013).Randomized Controlled Trial of Cetuximab Plus Chemotherapy for Patients With KRAS Wild-Type Unresectable Colorectal Liver-Limited Metastases.JOURNAL OF CLINICAL ONCOLOGY,31(16). |
MLA | Ye, Le-Chi,et al."Randomized Controlled Trial of Cetuximab Plus Chemotherapy for Patients With KRAS Wild-Type Unresectable Colorectal Liver-Limited Metastases".JOURNAL OF CLINICAL ONCOLOGY 31.16(2013). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论